enGene Therapeutics Inc. (ENGN) Q1 2025 Annual Earnings
ENGN·Reported March 10, 2025·Before market open
Diluted EPS came in at $-0.48, missed the $-0.37 consensus by $0.11.
Diluted EPS
$-0.48missed by $0.11
Consensus: $-0.37
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about enGene Therapeutics Inc. 's Q1 2025 earnings report.
enGene Therapeutics Inc. (ENGN) reported Q1 2025 earnings on March 10, 2025 before market open.
enGene Therapeutics Inc. reported diluted EPS of $-0.48 for Q1 2025.
EPS missed the consensus estimate of $-0.37 by $0.11.
You can read the 10-K/A periodic report (0000950170-25-024221) directly on SEC EDGAR. The filing index links above go to sec.gov.